Total consumer industry cross border M&A deals worth $1.24bn were announced globally in December 2020, led by Essity’s $408.79m acquisition of Asaleo Care, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 88% over the previous month of $10.32bn and a drop of 81.6% when compared with the last 12-month average, which stood at $6.74bn.
Comparing cross border M&A deals value in different regions of the globe, Asia-Pacific held the top position, with total announced deals in the period worth $545.93m. At the country level, the Australia topped the list in terms of deal value at $429.19m.
In terms of volumes, Europe emerged as the top region for consumer industry cross border M&A deals globally, followed by Asia-Pacific and then North America.
The top country in terms of cross border M&A deals activity in December 2020 was the US with eight deals, followed by the UK with five and China with four.
In 2020, as of December, consumer cross border M&A deals worth $49.46bn were announced globally, marking an increase of 40.6% year on year.
consumer industry cross border M&A deals in December 2020: Top deals
The top five cross border M&A deals accounted for 80.6% of the overall value during December 2020.
The combined value of the top five consumer cross border M&A deals stood at $995.67m, against the overall value of $1.24bn recorded for the month.
The top five consumer industry cross border M&A deals of December 2020 tracked by GlobalData were:
1) Essity’s $408.79m acquisition of Asaleo Care
2) The $269.69m acquisition of Maximo Fitness by Thrasio
3) Novozymes’ $128.29m acquisition of Microbiome Labs
4) The $96.9m acquisition of Shang Xia by EXOR
5) Hamad bin Khalifa Al Nahyan’s acquisition of Beitar Jerusalem for $92m.
